Furthermore, C. phaeocaulis– and S. stoloniferum–medicated serum might suppress TGF-β1–induced EMT in triple-negative breast cancer by decreasing the phosphorylated Smad3 pathway in vitro (Yin et al., 2018). Here, SMAD3 is linked to triple-negative breast carcinoma.